Journal
JOURNAL OF HUMAN GENETICS
Volume 63, Issue 3, Pages 319-326Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s10038-017-0382-y
Keywords
-
Categories
Funding
- JSPS (JSPS KAKENHI) [15J04964, 26461712, 25461723]
- Takeda Science Foundation in Japan
- Grants-in-Aid for Scientific Research [16K10193, 15H04709, 15H04891, 16H06399] Funding Source: KAKEN
Ask authors/readers for more resources
Major depressive disorder is a common psychiatric disorder that is thought to be triggered by both genetic and environmental factors. Depressive symptoms are an important public health problem and contribute to vulnerability to major depression. Although a substantial number of genetic and epigenetic studies have been performed to date, the detailed etiology of depression remains unclear and there are no validated biomarkers. DNA methylation is one of the major epigenetic modifications that play diverse roles in the etiology of complex diseases. In this study, we performed an epigenome-wide association study (EWAS) of DNA methylation on subjects with (N = 20) or without (N = 27) depressive symptoms in order to examine whether different levels of DNA methylation were associated with depressive tendencies. Employing methylationarray technology, a total of 363,887 methylation sites across the genomes were investigated and several candidate CpG sites associated with depressive symptoms were identified, especially annotated to genes linked to a G-protein coupled receptor protein signaling pathway. These data provide a strong impetus for validation studies using a larger cohort and support the possibility that G-protein coupled receptor protein signaling pathways are involved in the pathogenesis of depression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available